¦Ã-¹È°±Ëἤø(¦Ã-GK)ÊÔ¼ÁºÐ΢°å·¨/48Ñù
²â¶¨¹æ¸ñ£º48Ñù
ÓРЧ ÆÚ£º£¶¸öÔÂ
²â¶¨·½·¨£ºÎ¢°å·¨
±£´æÌõ¼þ£ºµÍαܹⱣ´æ
²úÆ·¼ò½é:
¦Ã-¹È°±Ëἤø(¦Ã-GK£¬EC 2.7.2.11)ÊǸ¬°±ËáÉúÎïºÏ³É;¾¶ÖеĹؼüø֮һ¡£´ß»¯ÓɹȰ±ËáÉú³É¸¬°±Ëá;¾¶µÄµÚÒ»²½·´Ó¦¡£±¾ÊÔ¼ÁºÐÀûÓæÃ-GK ´ß»¯¹È°±ËáÁ×Ëữ£¬½øÒ»²½Óëת»¯Îª¦Ã©¤¹È°±õ£»ùÒìôÇë¿ËᣬÔÚËáÐÔÌõ¼þÏÂÓëFe3+ÐÎ³É Hydroxamate-Fe3+¸´ºÏÎï £¬Í¨¹ý¼ì²â¸Ã¸´ºÏÎïÔÚ 535 nm ²¨³¤´¦µÄ OD Öµ£¬½ø¶øµÃ³ö¦Ã-GKø»îÁ¦´óС¡£¸Ãø´ß»¯µÄ·´Ó¦·½³Ìʽ£ºATP+L-glutamate=ADP+L-glutamate 5-phosphate¡£
ÊÔ¼ÁºÐ×é³ÉºÍÅäÖÆ:
|
ÊÔ¼ÁÃû³Æ |
¹æ¸ñ |
±£´æÒªÇó |
±¸×¢ |
|
ÌáȡҺ |
ÒºÌå60mL¡Á1Æ¿ |
4¡æ±£´æ |
|
|
ÊÔ¼ÁÒ» |
ÒºÌå5mL¡Á1Æ¿ |
4¡æ±£´æ |
|
|
ÊÔ¼Á¶þ |
·ÛÌåmg¡Á1Æ¿ |
4¡æ±£´æ |
ÁÙÓÃǰ˦¼¸Ï£¬Ê¹·ÛÌåÂäµ½µ×²¿£¬ ÔÙ¼ÓÈë 6mL ÕôÁóË®ÈܽⱸÓᣠ|
|
ÊÔ¼ÁÈý |
ÒºÌå5mL¡Á1Æ¿ |
4¡æ±£´æ |
|
|
ÊÔ¼ÁËÄ |
·ÛÌåmg¡Á1Ö§ |
4¡æ±£´æ |
ÁÙÓÃǰ˦¼¸Ï£¬Ê¹·ÛÌåÂäµ½µ×²¿£¬ ÔÙ¼ÓÈë 1.1mL ÕôÁóË®ÈܽⱸÓᣠ|
|
ÊÔ¼ÁÎå |
ÒºÌå10mL¡Á1Æ¿ |
4¡æ±£´æ |
|
ËùÐèµÄÒÇÆ÷ºÍÓÃÆ·:
ø±êÒÇ¡¢96 ¿×°å¡¢Ë®Ô¡¹ø¡¢ÀëÐÄ»ú¡¢¿Éµ÷Ê½ÒÆÒºÆ÷¡¢Ñв§¡¢±ùºÍÕôÁóË®¡£
¦Ã-¹È°±Ëἤø£¨¦Ã-GK£©»îÐԲⶨ:
½¨ÒéÕýʽʵÑéǰѡȡ 2 ¸öÑù±¾×öÔ¤²â¶¨£¬Á˽ⱾÅúÑùÆ·Çé¿ö£¬ÊìϤʵÑéÁ÷³Ì£¬±ÜÃâʵÑéÑù±¾ºÍÊÔ¼ÁÀË·Ñ£¡
¹ºÎï³µ
°ïÖú
021-54845833/15800441009
